MPMarzieh Pirzadeh

Marzieh Pirzadeh

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Marzieh Pirzadeh has a total of 29 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • HIF-1α gene/protein and oxidative stress in patients with colorectal cancer: A pilot study

    by Soroush Akbar, Mohammad Sadegh Fazeli, Romina Hemmati, Marzieh Pirzadeh, Seyedeh Maryam Seyedan, Gordon A. Ferns, Reza Pakzad, Zahra Yazdanian, Naser Mobarra

  • Open Access

    Clinicopathological Study of 307 Patients with Lichen Planus Actinicus and Pigmentosus Referred to Razi Skin Hospital from 2016 to 2021

    by Kambiz Kamyab, Zahra Gholi, Maryam Ghiasi, Marzieh Pirzadeh, Maryam Nasimi

    Citation: Kamyab K, Gholi Z, Ghiasi M, Pirzadeh M, Nasimi M. Clinicopathological Study of 307 Patients with Lichen Planus Actinicus and Pigmentosus Referred to Razi Skin Hospital from 2016 to 202. Dermatol Pract Concept. 2023;13(2):e2023119. DOI: https://doi.org/10.5826/dpc.1302a119 Accepted: November 30, 2022; Published: April 2023 Copyright: ©2023 Kamyab et al. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (BY-NC-4.0), https://creativecommons.org/licenses/by-nc/4.0/, which permits unrestricted noncommercial use, distribution, and reproduction in any medium, provided the original authors and source are credited. Funding: None. Competing interests: None. Authorship: All authors have contributed significantly to this publication. Corresponding author: Maryam Nasimi, Department of Dermatology, Razi Hospital, Tehran University of Medical Sciences, Vahdate Eslami Street, Tehran, Iran. Zip code: 1199663911 Tel: 00982155618989, Nsm.maryam@gmail.com Introduction: The two less-known subtypes of lichen planus (LP) are lichen planus actinicus (LPA) and lichen planus pigmentosus (LPP), with the highest prevalence in the Middle East. Objectives: We aimed to evaluate the clinicopathological profile of these patients. Methods: 307 cases including 184 LPA and 123 LPP patients were recruited from the registered pathology reports of Razi Skin Hospital of Tehran from April 2016 to March 2021. The clinical features and pathological reports were extracted and analyzed. Results: Among 307 patients, 117 (63.9%) in the LPA group and 88 (71.5%) in the LPP group were women. Duration of disease ranged from 1 month to 20 years and 1 month to 12 years in the LPA and LPP groups, respectively. Face (159 patients), limbs (68), and neck (23) were the most frequent sites of involvement in LPA patients, whereas face (60 patients), limbs (47), and trunk (42) were more commonly involved in the LPP patients. Pruritus and oral mucosal lesions were found with similar frequency in both groups. Pathological evaluation showed vacuolar degeneration of basal layer (100%), lymphocytes infiltration (97.3%), and melanin incontinence (58.2%) as the most frequent findings in LPA and vacuolar degeneration of basal layer (100%), lymphocytes infiltration (100%), and melanin incontinence (52/8%) as the most frequent findings in LPP cases.Conclusion: LPA and LPP were both more prevalent among women. Face was the most common site of involvement in both LPA and LPP. Vacuolar degeneration, lymphocyte infiltration, melanin incontinence, and hyperkeratosis were more common histological findings in this study. Keywords : lichen planus actinicus, lichen planus pigmentosus, clinicopathology, vacuolar degeneration This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.


  • Open Access

    Galangin Nanoparticles Protect Acetaminophen-Induced Liver Injury: A Biochemical and Histopathological Approach

    by Arezoo Mohammadi, Sohrab Kazemi, Inas Molayousefian, Marzieh Pirzadeh, Ali Akbar Moghadamnia

    One of the main causes of acute liver failure is overdose with acetaminophen. Excessive consumption of acetaminophen leads to the production of NAPQI (N-acetyl-p-benzoquinone imine) through the activity of the enzyme cytochrome c oxidase. For this purpose, the effect of galangin nanoparticles with antioxidant activities will be evaluated for the treatment of acetaminophen-induced hepatotoxicity. In this study, after the synthesis of galangin nanoparticles and particle size determination, mice were divided into six groups. Before treatment, a single dose (350 mg/kg) of acetaminophen was administered by gavage in all groups. The activity of alanine aminotransferase (ALT), aspartate aminotransferase (AST), alkaline phosphatase (ALP), as well as biochemical factors FRAP and MDA in serum were measured and a histopathological study was performed. The prepared nanoparticles produced in this research were characterized by the SEM, DLS, and ZETA potential, and the average particle size was obtained in the range of 150 nm. Serum levels of liver enzymes (AST and ALT) in the nanoparticle group decreased significantly compared with the control group ( ). In the group without treatment, the activity of aspartate aminotransferase (AST) and alanine aminotransferase (ALT) enzymes increased significantly compared with the treatment groups. Also, galangin nanoparticles, at a dose of 20 mg/kg, improve cell damage in hepatocytes and preserve the tissue structure of the liver. Galangin nanoparticles reduce the acetaminophen-induced hepatotoxicity by reducing the number of liver function indices. According to our findings, the liver-protective effects of the nanoparticle may be due to its antioxidant properties.


  • Open Access

    Protective Effect of Kaempferol and Its Nanoparticles on 5‐Fluorouracil‐Induced Cardiotoxicity in Rats

    by Soheila Safarpour, Marzieh Pirzadeh, Anahita Ebrahimpour, Fatemeh Shirafkan, Fateme Madani, Mohammad Hosseini, Ali Akbar Moghadamnia, Sohrab Kazemi

    Background. Fluorouracil (5‐FU) is the third most common chemotherapeutic agent used in the treatment of solid tumors. 5‐FU‐associated cardiotoxicity ranks the second causes of cardiotoxicity induced by chemotherapeutic drugs after anthracyclines. Kaempferol (KPF), a common flavonoid, possessing anti‐inflammatory, antiapoptotic, antioxidative properties, and its protective effects on cardiovascular disease has been reported in various studies. The current study is aimed at appraising the effect of KPF and KPF nanoparticles (NPs) on 5‐FU‐induced cardiotoxicity in rats. Methods. Thirty Male Wistar rats were divided into five groups as follows: control, 5‐FU, 5‐FU+10 mg/kg vitamin C, 5‐FU+ 1 mg/kg KPF, and 5‐FU+ 1 mg/kg KPF‐NPs. Cardiotoxicity was induced with an intraperitoneal injection of a single dose of 5‐FU (100 mg/kg). The control group received normal saline, and the treatment groups received KPF and KPF‐NPs with an intraperitoneal injection for 14 days. Each heart histopathological lesions were given a score of 0 to 3 in compliance with the articles for statistical analysis. Results. 5‐FU resulted in a significant cardiotoxicity represented by an increase in cardiac enzymes, MDA (malondialdehyde) levels, COX‐2 (cyclooxygenase‐2) expression, and histopathological degenerations. 5‐FU treatment also decreased body weight, TAC (total antioxidant capacity) values, VEGF (vascular endothelial growth factor) expression, blood cells, and hemoglobin (Hb) levels. Treatment with KPF and KPF‐NPs reduced oxidative stress, cardiac enzymes, COX‐2 expression, and VEGF expression. The number of blood cells, Hb levels, and histopathological degenerations, in cardiac tissue also body weight of animals, increased, followed by treatment with KPF and KPF‐NPs. Conclusion. Our results demonstrated that treatment with KPF and KPF‐NPs significantly improved cardiotoxicity induced by 5‐FU in rats.


  • Open Access

    Polypill's cardiovascular and non-cardiovascular mortalities

    by Davood Khalili, Farzad Hadaegh, Marzieh Pirzadeh, Fereidoun Azizi

  • The interplay between aryl hydrocarbon receptor, H. pylori, tryptophan, and arginine in the pathogenesis of gastric cancer

    by Marzieh Pirzadeh, Nastaran Khalili, Nima Rezaei

    Several risk factors are known to be involved in the initiation and development of gastric cancer. Among them, H. pylori is one of the most prominent with multiple virulence factors contributing to its pathogenicity. In this study, we have discussed an interesting immunological cycle exploring the interplay between H. pylori, aryl hydrocarbon receptor (AHR), tryptophan, arginine, and the metabolites of these two amino acids in the development of gastric cancer. AHR is a ligand-activated transcription factor which acts as a regulator for a diverse set of genes and has various types of exogenous and endogenous ligands. The tryptophan metabolite, kynurenine, is one of these ligands that can interact with AHR, leading to immune suppression and subsequently, susceptibility to gastric cancer. On the other hand, H. pylori downregulates the expression of AHR and AHR repressor (AHRR), leading to increased inflammatory cytokine production. A metabolite of the kynurenine pathway, xanthurenic acid, is a potent inhibitor of a terminal enzyme in the synthetic pathway of tetrahydrobiopterin (BH4). BH4, itself, is a cofactor in the process of nitric oxide (NO) production from arginine that has been shown to have immune-enhancing properties. Arginine has also been evidenced to have anti-tumoral function through inducing apoptosis in gastric cell lines; however, controversy exists regarding the anti-tumor role of arginine and BH4, since they are also associated with increased NO production, subsequently promoting tumor angiogenesis. Hence, although several synergistic connections result in immunity improvement, these correlations can also act as a double-edged sword, promoting tumor development. This emphasizes on the need for further investigations to better understand this complex interplay.